ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,937Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 298

$687K Total Retail Price of All Prescriptions

Rank: 7 out of 298

344 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 344 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 344 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 9,298 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
SIMVASTATIN 447 410 1 2
OMEPRAZOLE 396 342 2 3
LEVOTHYROXINE SODIUM 384 360 3 1
METFORMIN HCL 292 222 4 10
LISINOPRIL 277 243 5 4
METOPROLOL SUCCINATE 240 239 6 12
AMLODIPINE BESYLATE 222 200 7 6
TRAMADOL HCL 205 169 8 15
CITALOPRAM HBR 198 189 9 17
FUROSEMIDE 198 168 9 5
POTASSIUM CHLORIDE 181 147 11 11
ATORVASTATIN CALCIUM 180 179 12 14
GABAPENTIN 171 160 13 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 171 163 13 30
ATENOLOL 144 143 15 16
WARFARIN SODIUM 142 134 16 7
HYDROCHLOROTHIAZIDE 140 140 17 13
SERTRALINE HCL 139 125 18 19
PREDNISONE 134 108 19 33
ALENDRONATE SODIUM 133 133 20 21
LOSARTAN POTASSIUM 130 106 21 18
SPIRONOLACTONE 127 102 22 34
HYDROCODONE-ACETAMINOPHEN 122 85 S3 23 8
METOPROLOL TARTRATE 114 102 24 9
ESCITALOPRAM OXALATE 113 98 25 89
ZOLPIDEM TARTRATE 108 91 26 25
NEXIUM 108 86 26 40
CLOPIDOGREL 108 101 26 36
SPIRIVA 100 89 29 55
TAMSULOSIN HCL 94 90 30 24
CRESTOR 87 87 31 26
VENLAFAXINE HCL ER 86 61 32 90
DIGOXIN 84 66 33 27
JANUVIA 83 66 34 73
GLIPIZIDE 80 65 35 69
VESICARE 77 76 36 149
NAMENDA 77 77 36 35
TRIAMTERENE-HCTZ 76 75 38 43
ACETAMINOPHEN-CODEINE 75 55 S3 39 119
PLAVIX 72 72 40 70
RISPERIDONE 71 67 41 54
ADVAIR DISKUS 69 63 42 46
LOSARTAN-HYDROCHLOROTHIAZIDE 67 67 43 44
CARBIDOPA-LEVODOPA 67 67 43 49
TRAZODONE HCL 62 57 45 39
ISOSORBIDE MONONITRATE ER 58 58 46 45
PAROXETINE HCL 57 45 47 48
GLIMEPIRIDE 55 55 48 60
AMITRIPTYLINE HCL 54 39 R 49 51
QUETIAPINE FUMARATE 54 51 49 68
LANTUS 54 39 49 53
LEVEMIR FLEXPEN 53 53 52 231
CARVEDILOL 52 45 53 23
PRAVASTATIN SODIUM 52 42 53 31
GEMFIBROZIL 50 32 55 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.